Secondary Logo

Journal Logo

Articles by Charles T. Esmon

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

Vincent, Jean-Louis; Ramesh, Mayakonda K.; Ernest, David; More

Critical Care Medicine. 41(9):2069-2079, September 2013.